14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ACAD stock ended at $17.13. This is 0.696% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 2.24% from a day low at $16.95 to a day high of $17.33.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jan 22, 2024 $27.41 $28.15 $27.28 $27.76 1 241 705
Jan 19, 2024 $27.68 $27.68 $27.01 $27.29 2 317 124
Jan 18, 2024 $28.13 $28.13 $26.99 $27.59 1 431 097
Jan 17, 2024 $28.62 $28.72 $27.52 $27.98 1 653 608
Jan 16, 2024 $28.61 $29.18 $28.28 $28.95 1 391 002
Jan 12, 2024 $29.15 $29.29 $28.44 $28.73 954 566
Jan 11, 2024 $29.02 $29.30 $27.93 $28.80 1 693 783
Jan 10, 2024 $30.68 $31.10 $29.10 $29.30 1 957 722
Jan 09, 2024 $29.66 $30.79 $29.32 $30.66 1 332 242
Jan 08, 2024 $30.01 $30.21 $29.50 $30.13 2 380 515
Jan 05, 2024 $29.59 $30.54 $29.39 $30.33 1 218 986
Jan 04, 2024 $29.74 $30.04 $29.14 $29.95 1 441 197
Jan 03, 2024 $30.83 $30.83 $29.24 $29.57 1 457 965
Jan 02, 2024 $31.09 $31.82 $30.63 $30.86 1 627 988
Dec 29, 2023 $31.70 $31.80 $31.18 $31.31 1 261 781
Dec 28, 2023 $31.66 $31.92 $31.26 $31.39 895 430
Dec 27, 2023 $31.12 $31.93 $30.75 $31.77 1 251 428
Dec 26, 2023 $31.75 $31.75 $31.10 $31.13 911 169
Dec 22, 2023 $30.10 $32.59 $30.07 $31.40 2 324 033
Dec 21, 2023 $29.56 $29.92 $28.97 $29.52 1 182 467
Dec 20, 2023 $30.08 $30.31 $29.00 $29.05 1 599 338
Dec 19, 2023 $30.20 $30.47 $29.09 $30.13 2 550 035
Dec 18, 2023 $28.50 $29.37 $28.15 $29.02 1 878 622
Dec 15, 2023 $28.30 $29.45 $27.94 $28.58 4 397 661
Dec 14, 2023 $27.24 $28.80 $27.22 $28.06 2 860 914
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT